Pablo Mozas

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 24

Top Venues

Hematological oncology

British journal of haematology

Leukemia & lymphoma

Blood advances

This page only lists publications with an associated author ORCID identifier.

Publications

Miguel Arguello-Tomas, Pablo Mozas, Nil Albiol, Miguel López-Esteban, Jorge Sierra, Josep Nomdedéu, Carolina Martinez-Laperche, Esther Moga, Juan A Piñeyroa, Julio Delgado, Santiago Osorio, Carol Moreno
Risk scores predicting disease progression in early-stage CLL: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy. Cancer (2024)
Maria Carmen Martinez Munoz, Esther Carcelero, Antonio Gutiérrez, Esther Sancho, Josep Maria Martí-Tutusaus, Laura Magnano, Pablo Mozas, Francesc Fernández-Avilés, María Gabriela Antelo, Xavier Setoain, Sonia Rodríguez, Jordi Esteve
Efficacy of escalating therapy with brentuximab vedotin-AVD in advanced stage Hodgkin lymphoma patients with positive interim positron emission tomography after ABVD. Hematological oncology 42 (5) (2024)
Núria Martínez-Cibrián, Valentín Ortiz-Maldonado, Marta Español-Rego, Andrea Blázquez, Joan Cid, Miquel Lozano, Laura Magnano, Eva Giné, Juan G Correa, Pablo Mozas, Luis Gerardo Rodríguez-Lobato, Andrea Rivero, Mercedes Montoro-Lorite, Pilar Ayora, Sergio Navarro, Leticia Alserawan, E Azucena González-Navarro, Maria Castellà, María Sánchez-Castañón, Raquel Cabezón, Daniel Benítez-Ribas, Xavier Setoaín, Sonia Rodríguez, Helena Brillembourg, Sara Varea, Eulalia Olesti, Elena Guillén, Joaquín Sáez-Peñataro, Carlos Fernández de Larrea, Armondo López-Guillermo, Mariona Pascal, Álvaro Urbano-Ispizua, Manel Juan, Julio Delgado
The academic point-of-care anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel (ARI-0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma. British journal of haematology (2023)
Ferran Nadeu, Charlotte Syrykh, Berta Pons-Brun, Núria Russiñol, Heribert Playa-Albinyana, Tycho Stephan Baumann, Martí Duran-Ferrer, Marta Kulis, Anna Carbó-Meix, Pablo Mozas, Miguel Alcoceba, Marcos González-Díaz, Almudena Navarro-Bailón, Enrique Colado, Ángel Payer, Marta Aymerich, María José Terol, JunYan Lu, Binyamin Asher Knisbacher, Cynthia K Hahn, Sílvia Ruiz-Gaspà, Anna Enjuanes, Catherine J Wu, Gad Getz, Thorsten Zenz, Armando López-Guillermo, José Ignacio Martin-Subero, Dolors Colomer, Julio Delgado, Elias Campo
IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia. Blood advances (2023)
Ana Muntañola, María Teresa Villalobos, Sonia González-Villambrosia, María José Rodríguez-Salazar, Ana Jiménez-Ubieto, Gabriela Bastidas-Mora, Raul Cordoba, María Infante, María Jesús Vidal, Francisco Javier Díaz, Mónica Baile, Mariana Bastos-Oreiro, Carlos Panizo, Juan-Manuel Sancho, Belén Navarro, Tomás García, Lourdes Escoda, Pau Abrisqueta, María José Terol, Raquel de Campo, Pablo Mozas, Armondo López-Guillermo, Antonio Salar-Silvestre, Carlos Montalbán, null null
Low-risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study. British journal of haematology (2023)
Pablo Mozas, Sebastián Casanueva-Eliceiry, Andrea Rivero, Ángel Serna, Marc Simó, Sonia Rodríguez, Alfredo Rivas-Delgado, Ferran Nadeu, Juan Gonzalo Correa, Juan Antonio Piñeyroa, Amanda Isabel Pérez-Valencia, Katia Guinetti-Ortiz, Marta Gómez-Hernando, Eva Giné, Julio Delgado, Neus Villamor, Elías Campo, Laura Magnano, Pau Abrisqueta, Xavier Setoain, Armando López-Guillermo
A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphoma. Hematological oncology (2023)
Pablo Mozas, Cristina López, Marta Grau, Ferran Nadeu, Guillem Clot, Sara Valle, Marta Kulis, Alba Navarro, Joan Enric Ramis-Zaldivar, Blanca González-Farré, Alfredo Rivas-Delgado, Andrea Rivero, Gerard Frigola, Olga Balagué, Eva Giné, Julio Delgado, Neus Villamor, Estella Matutes, Laura Magnano, Ramón García-Sanz, Sarah Huet, Robert B Russell, Elías Campo, Armando López-Guillermo, Sílvia Beà
Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors. Hematological oncology (2023)
Ana Muntañola, Pablo Mozas, Santiago Mercadal, Maria Huguet, Sabela Bobillo, Mariana Bastos-Oreiro, Ana Jiménez-Ubieto, Jordina Rovira, Andrea Rivero, Carles Tolosa, Luis Luizaga, Sonia González de Villambrosia, Silvana Novelli, Dolores Caballero, Antonio Salar, Sara Alonso-Álvarez, Laura Magnano, Norma C Gutiérrez, Juan-Manuel Sancho, Armondo López-Guillermo, null null
Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcome. British journal of haematology (2022)
Alex Bataller, Ana Garrido, Francisca Guijarro, Guadalupe Oñate, Marina Diaz-Beyá, Montserrat Arnan, Mar Tormo, Susana Vives, María Paz Queipo de Llano, Rosa Coll, David Gallardo, Ferran Vall-Llovera, Lourdes Escoda, Antonio Garcia-Guiñon, Olga Salamero, Maria Antonia Sampol, Brayan M Merchan, Joan Bargay, Sandra Castaño-Díez, Daniel Esteban, Marta Garrote, Andrea Rivero, Pablo Mozas, Mònica López-Guerra, Marta Pratcorona, Lurdes Zamora, Dolors Costa, Maria Rozman, Josep F Nomdedéu, Dolors Colomer, Salut Brunet, Jorge Sierra, Aleksandra Holowiecka
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol. Blood advances 6 (4) (2022)
Alfredo Rivas-Delgado, Ferran Nadeu, Marcio Andrade-Campos, Katrin S Kurz, Anna Enjuanes, Pablo Mozas, Gerard Frigola, Lluís Colomo, Blanca Sanchez-Gonzalez, Neus Villamor, Sílvia Beà, Elías Campo, Antonio Salar-Silvestre, Eva Giné, Armando López-Guillermo, Beatriz Bellosillo
Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma. Diagnostics (Basel, Switzerland) 12 (7) (2022)
Nadia Güell, Pablo Mozas, Alba Jimenez-Rueda, Milos D Miljkovic, Jordi Juncà, Marc Sorigue
Methodological and conceptual challenges to the flow cytometric classification of leukemic lymphoproliferative disorders. Critical reviews in clinical laboratory sciences (2022)
Juan A Piñeyroa, Laura Magnano, Andrea Rivero, Alfredo Rivas-Delgado, Ferran Nadeu, Juan Gonzalo Correa, Eva Giné, Neus Villamor, Xavier Filella, Dolors Colomer, Mònica López, Irene López-Oreja, Dolors Costa, Marta Aymerich, Sílvia Beà, Armando López-Guillermo, Elías Campo, Julio Delgado, Pablo Mozas
Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia. Hematological oncology 40 (4) (2022)
Pablo Mozas, Armondo López-Guillermo
Response to: The lymphocyte-to-monocyte ratio in follicular lymphoma. Leukemia & lymphoma 62 (10) (2021)
Pablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, Ferran Nadeu, Juan Gonzalo Correa, Carlos Castillo, Alex Bataller, Tycho Baumann, Eva Giné, Julio Delgado, Neus Villamor, Elías Campo, Laura Magnano, Armando López-Guillermo
Age and comorbidity are determining factors in the overall and relative survival of patients with follicular lymphoma. Annals of hematology 100 (5) (2021)
Alex Bataller, Francisca Guijarro, Aurélie Caye, Marion Strullu, Arthur Sterin, William C Earnshaw, Patrice Chevallier, Marketa Zaliova, Jan Zuna, Pablo Mozas, Laura Magnano, Nathalie Grardel, Pascale Cornillet-Lefebvre, Jen-Fen Fu, Lee-Yung Shih, Temenuzhka Boneva, Elisabeth P Nacheva, Sílvia Beà, Mónica López-Guerra, Clara Bueno, Pablo Menéndez, Jordi Esteve, Patrizia Larghero, Claus Meyer, Rolf Marschalek
KMT2A-CBL rearrangements in acute leukemias: clinical characteristics and genetic breakpoints. Blood advances (2021)
Pablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, Juan Gonzalo Correa, Maria Condom, Ferran Nadeu, Eva Giné, Julio Delgado, Neus Villamor, Elías Campo, Laura Magnano, Armando López-Guillermo
Prognostic ability of five clinical risk scores in follicular lymphoma: A single-center evaluation. Hematological oncology 39 (5) (2021)
Pablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, Ferran Nadeu, Eva Giné, Julio Delgado, Neus Villamor, Elias Campo, Patricia Pérez-Galán, Laura Magnano, Armondo López-Guillermo
The Prognostic Nutritional Index (PNI) is an independent predictor of overall survival in older patients with follicular lymphoma. Leukemia & lymphoma (2021)
Ivan Dlouhy, Kennosuke Karube, Anna Enjuanes, Itziar Salaverria, Ferran Nadeu, Juan Enric Ramis-Zaldivar, Juan G Valero, Alfredo Rivas-Delgado, Laura Magnano, David Martin-García, Patricia Pérez-Galán, Guillem Clot, Jordina Rovira, Pedro Jares, Olga Balagué, Eva Giné, Pablo Mozas, Javier Briones, Juan-Manuel Sancho, Antonio Salar, Santiago Mercadal, Miguel Alcoceba, Alexandra Valera, Elías Campo, Armondo López-Guillermo
Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma. British journal of haematology (2021)
Pablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, Juan Gonzalo Correa, Maria Condom, Ferran Nadeu, Eva Giné, Julio Delgado, Neus Villamor, Elías Campo, Laura Magnano, Armando López-Guillermo
First external validation of the FLIPI-L score in a single-center series of patients with follicular lymphoma. Hematological oncology (2021)
Pablo Mozas, Marc Sorigue, Alfredo Rivas-Delgado, Andrea Rivero, Juan Gonzalo Correa, Carlos Castillo, Ferran Nadeu, Alex Bataller, Eva Giné, Tycho Baumann, Julio Delgado, Neus Villamor, Elias Campo, Laura Magnano, Juan-Manuel Sancho, Armondo López-Guillermo
The interval between frontline treatment and the second relapse (PFS2) predicts survival from the second relapse in follicular lymphoma patients. European journal of haematology 106 (3) (2020)
Pablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, Aleix Fabregat, Juan A Piñeyroa, Juan G Correa, Ferran Nadeu, Marta Garrote, Alex Bataller, Eva Giné, Julio Delgado, Neus Villamor, Maria T Cibeira, Carlos Fernández de Larrea, Laura Rosinol, Elías Campo, Juan I Aróstegui, Joan Bladé, Laura Magnano, Armando López-Guillermo
Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphoma. British journal of haematology 193 (2) (2020)
Pablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, Ferran Nadeu, Guillem Clot, Juan Gonzalo Correa, Carlos Castillo, Alex Bataller, Tycho Baumann, Eva Giné, Julio Delgado, Neus Villamor, Elias Campo, Patricia Pérez-Galán, Laura Magnano, Armondo López-Guillermo
A low lymphocyte-to-monocyte ratio is an independent predictor of poorer survival and higher risk of histological transformation in follicular lymphoma. Leukemia & lymphoma 62 (1) (2020)
Alfredo Rivas-Delgado, Ferran Nadeu, Anna Enjuanes, Sebastián Casanueva-Eliceiry, Pablo Mozas, Laura Magnano, Natalia Castrejon, Jordina Rovira, Ivan Dlouhy, Silvia Martín, Miguel Osuna, Sonia Rodríguez, Marc Simó, Magda Pinyol, Tycho Baumann, Sílvia Beà, Olga Balagué, Neus Villamor, Xavier Setoain, Elias Campo, Eva Giné, Armondo López-Guillermo
Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (2) (2020)
Pablo Mozas, Ferran Nadeu, Alfredo Rivas-Delgado, Andrea Rivero, Marta Garrote, Olga Balagué, Blanca González-Farré, Luis Veloza, Tycho Baumann, Eva Giné, Julio Delgado, Neus Villamor, Elias Campo, Laura Magnano, Armando López-Guillermo
Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience. Blood cancer journal 10 (3) (2020)

Pablo Mozas.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pablo Mozas